UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Emergent BioSolutions is implementing good security practices.
Emergent BioSolutions is a multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland, USA. It develops vaccines and antibody therapeutics for infectious diseases, oncology and autoimmune disorders, and provides medical devices for biodefense purposes. Among the company's notable products is BioThrax (Anthrax Vaccine Adsorbed), the only anthrax vaccine licensed by the U.S. Food and Drug Administration (FDA).
This report shows a preliminary security rating for Emergent BioSolutions. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
A cyber attack (or cyberattack) is any attempt to expose, alter, disable, destroy, steal or gain ...
Vendor risk management (VRM) deals with the management and monitoring of risks resulting from ...
Compare Emergent BioSolutions's security performance with other companies